Search PubMed⌕ Search

PubMed · 7415923

Recognizing coccidioidomycosis.

Abstract

Primary pulmonary coccidioidomycosis is usually a self-limited disease. It is characterized by fever, nonproductive cough and chest pain. Manifestations of hypersensitivity, such as skin lesions and polyserositis, are often present. Persistence of symptoms beyond eight weeks, continuously positive sputum cultures or negative skin tests with high serum complement-fixation titers for coccidiodomycosis suggest local progression or hematogenous spread. These situations are indications for antifungal therapy.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A S Bayer. 1980. Recognizing coccidioidomycosis.. https://pubmed.ncbi.nlm.nih.gov/7415923/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Allergic bronchopulmonary aspergillosis: a US perspective.

PURPOSE OF REVIEW: The present article is an update of allergic bronchopulmonary aspergillosis. Although a rare condition, allergic bronchopulmonary aspergillosis does affect a number of patients with asthma and cystic fibrosis. Prompt recognition and treatment of the disease is critical to improving patient outcomes. RECENT FINDINGS: There is currently much active research being performed in the area of allergic bronchopulmonary aspergillosis. Fascinating insights are being made into the pathophysiology and genetics of the disease. Additionally, research is ongoing on the use of recombinant Aspergillus allergens as an aid to the diagnosis of allergic bronchopulmonary aspergillosis. SUMMARY: These new insights into the genetics and pathophysiology of allergic bronchopulmonary aspergillosis and the development of these new diagnostic techniques could ultimately lead to improved patient treatment. These areas form an important basis for further research.

Antibodies, Fungal↗

Diagnosis of Paracoccidioidomycosis by detection of antigen and antibody in bronchoalveolar lavage fluids.

Paracoccidioidomycosis (PCM) is a systemic infection caused by the fungus Paracoccidioides brasiliensis and is believed to be the leading cause of fungal pulmonary infection. In this study, we used an inhibition enzyme-linked immunosorbent assay to diagnose pulmonary PCM based on the detection of 43-kDa and 70-kDa molecules in bronchoalveolar lavage fluids. The results were compared with results obtained by classical methods for antibody detection.

Antibodies, Fungal↗